Pharmaron Beijing Co., Ltd.
300759
株式のランク
#2354
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a... Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
株価
$5.58
時価総額
$8.24B
変化（1日）
-3.77%
変化（1年）
28.36%
国
CN
取引 Pharmaron Beijing Co., Ltd. (300759)
カテゴリー
Healthcare
Pharmaron Beijing Co., Ltd.（300759）の配当利回りの履歴
Pharmaron Beijing Co., Ltd.（銘柄コード: 300759）の配当利回り（TTM）は2024-12-31時点で1.19%です。
過去5年間の平均配当利回り: 0.81%
過去5年間の平均配当利回り: 0.81%
Pharmaron Beijing Co., Ltd.（300759）の2014から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
| 年 | 配当利回り | 変化 |
|---|---|---|
| 2026 (TTM) | 0.54% | -49.06% |
| 2025 | 1.06% | -10.92% |
| 2024 | 1.19% | 38.37% |
| 2023 | 0.86% | 95.45% |
| 2022 | 0.44% | -8.33% |
| 2021 | 0.48% | 71.43% |
| 2020 | 0.28% | -41.67% |
| 2019 | 0.48% | -80.65% |
| 2018 | 2.48% | 78.42% |
| 2017 | 1.39% | 256.41% |
| 2016 | 0.39% | -39.06% |
| 2015 | 0.64% | 6.67% |
| 2014 | 0.60% | 0.00% |
類似企業または競合他社の配当利回り（TTM）
| 企業 | 配当利回り | 国 |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.07% |
AU
|
|
| 0.56% |
BE
|
|
| 0.00% |
NL
|
